We consider a symmetric scalar theory with quartic coupling in 4-dimensions. We show that the 4 loop 2PI calculation can be done using a renormalization group method. The calculation involves one bare coupling constant which is introduced at the level of the Lagrangian and is therefore conceptually simpler than a standard 2PI calculation, which requires multiple counterterms. We explain how our method can be used to do the corresponding calculation at the 4PI level, which can not be done using any known method by introducing counterterms. * carrington@brandonu.ca †
It is well known that perturbative pressure calculations show poor convergence. Calculations using a two particle irreducible (2PI) effective action show improved convergence at the 3 loop level, but no calculations have been done at 4 loops. We consider the 2PI effective theory for a symmetric scalar theory with quartic coupling in 4-dimensions. We calculate the pressure and two different non-perturbative vertices as functions of coupling and temperature. Our results show that the 4 loop contribution can become larger than the 3 loop term when the coupling is large. This indicates a breakdown of the 2PI approach, and the need for higher order nPI approximations. In addition, our results demonstrate the renormalizability of 2PI calculations at the 4 loop level. This is interesting because the counterterm structure of the 2PI theory at 4 loops is different from the structure at n ≤ 3 loops. Two vertex counterterms are required at the 4 loop level, but not at lower loop order. This unique feature of the 2PI theory has not previously been verified numerically.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.